Esperion Therapeutics
ESPR
#6464
Rank
A$1.14 B
Marketcap
A$4.45
Share price
0.32%
Change (1 day)
141.10%
Change (1 year)

EPS for Esperion Therapeutics (ESPR)

EPS in 2025 (TTM): A-$0.79

According to Esperion Therapeutics's latest financial reports the company's current EPS (TTM) is A-$0.71. In 2024 the company made an earnings per share (EPS) of A-$0.33 an increase over its 2023 EPS that were of A-$3.01.

EPS history for Esperion Therapeutics from 2014 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A-$0.79141%
2024A-$0.33-89.15%
2023A-$3.01-40.28%
2022A-$5.03-62.87%
2021A-$13.5580.38%
2020A-$7.5150.14%
2019A-$5.00-53.18%
2018A-$10.697.41%
2017A-$9.95110.81%
2016A-$4.7247.35%
2015A-$3.200.89%
2014A-$3.18

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
A$1.86-362.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
A$60.29-8,606.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
A-$8.66 1,122.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
A-$0.27-62.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
A-$0.16-78.00%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$1.98-380.00%๐Ÿ‡บ๐Ÿ‡ธ USA